News
Update September 2019
- Details
Find our latest ‘Update’ here for an overview of the latest news on the BioMed Alliance in September.
Open letter to the Members of the European Parliament on sustaining EU progress in fighting against antimicrobial resistance (AMR)
- Details
The BioMed Alliance has joined an informal group of 16 other organisations active in human and animal health and signed an open letter to the Members of the European Parliament on antimicrobial resistance (AMR). AMR is an emerging worldwide threat to both human and animal health. The letter urges Members of Parliament to bring antimicrobial resistance to the forefront of EU interinstitutional discussions and to support the establishment of a dedicated AMR parliamentary group.
EU Health Coalition Statement: establish balanced Horizon Europe that fosters research & innovation
- Details
The EU health coalition published a new statement calling for a balanced Horizon Europe that fosters both research and innovation and supports cross-fertilisation and collaboration across the framework programme’s pillars and clusters. As leader of the Coalition’s research and innovation group, the BioMed Alliance played an important role in drafting the statement.
In light of the open consultation on Horizon Europe’s Strategic Plan, the BioMed Alliance and its partners call for a balanced approach which ensures cross-fertilisation and coordination across all relevant disciplines. This is particularly important in health research as this can benefit from efforts in multiple clusters and programmes.
Event 12 September: Brexit: the European Parliament’s role in prioritising patients, public health and health security across Europe
- Details
On 12 September, the BioMed Alliance is joining a number of stakeholders for an event on Brexit and the European Parliament’s role in prioritising patients, public health and health security across Europe. At a critical time when there is a very strong risk of a no-deal scenario, the big questions concerning Brexit for patients across the whole EU remain unanswered. This event will focus on explaining to new MEPS the challenges of safeguarding public health and health security. It will also highlight what the European Parliament can do to follow up on its resolution from 14 March 2018 to ensure that the new European Commission is aware of the challenges and is acting to mitigate the risks.
DRAFT AGENDA
| Time | Speaker and Subject |
| 10:00-10:05 | Introduction and welcome |
| 10:05-10:20 | Usman Khan, Executive Director European Patient’s Forum - key concerns for European patients |
| 10:20-10:35 | Professor George Griffin, President, Federation of European Academies of Medicine– safeguarding European medical research post Brexit |
| 10:35-10:50 | Fiona Godfrey, Secretary General, European Public Health Alliance, preserving public health |
| 10:50-11:05 | David Boyd, Astrazeneca, access to and safety of medicines and medical devices |
| 11:05-11:20 | Pascal Garel, Secretary General, European Hospital and Healthcare Federation, challenges facing European hospitals |
| 11:20-11:40 | Question and Answers |
| 11:40-11:50 | Concluding remarks |
The event takes place on Thursday 12 September from 10.00-12.00 in the European Parliament, Room A3G2. Registration: https://forms.gle/6HWVZ7wBGpfQk2Wt7
For more information, read our Briefing on the consequences of Brexit on health and health research here: Download
Update August 2019
- Details
Our August Update is available now, take a look here to see what the BioMed Alliance has been up to.
Update July 2019
- Details
Take a look at our brand-new update to read about our activities in July and other related developments at EU level.
ERA-EDTA joins the BioMed Alliance
- Details
The latest organisation to join the BioMed Alliance is the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA). This new addition brings the total number of members to 31. We look forward to working with ERA-EDTA to continue promoting heath research and to improve health-related policy at EU level.
ERA-EDTA is specialised in nephrology and represents more than 7.000 physicians. It is active in Europe and the Mediterranean and it aims to promote fundamental clinical advances in the field of nephrology, dialysis, renal transplantation, hypertension and related subjects.
Medical societies urge Member States to support EU-level HTA
- Details
Today, as the incoming Finnish EU Presidency prepares to take up the HTA legislative dossier, the Biomedical Alliance in Europe (BioMed Alliance) commends the dedication of previous EU Presidencies and it calls on the Council of the European Union to support the legislative proposal so that there can be a robust and effective framework for collaborative EU-level HTA.
Update June 2019
- Details
Read the BioMed Alliance Update for an overview of our activities and other relevant news in June.
The BioMed Alliance together with the EU Health Coalition partners call upon the European Council to increase the total Horizon Europe budget to € 120 billion
- Details
Ahead of the European Council Meeting (20-21 June), the BioMed Alliance calls upon Member States to adopt a Multiannual Financial Framework as well as a Horizon Europe budget which echo Europe’s ambition for innovation in research
Press Release: Providing Evidence for Regulators - Workshop on Medical Device Registries
- Details
On 17 June, the BioMed Alliance, ESC and EFORT released a press release announcing that they are holding a joint workshop on Medical Device Registries.
Open Joint Letter with EPF and ESC: Urgent investment needed to ensure EU Medical Devices Regulation should is implemented on time
- Details
The Biomedical Alliance in Europe has releases an open letter to EU Health Ministers with the European Patients Forum (EPF) and the European Society of Cardiology (ESC) calling for urgent investment to ensure that the EU Medical Devices Regulation (MDR) is implemented on time.
Update May 2019
- Details
Workshop on Medical Device Registries
- Details
The BioMed Alliance, together with the European Society of Cardiology (ESC) and the European Federation of National Associations of Orthopaedics and Traumatology (EFORT), are organising a Joint Workshop on Medical Device Registries on 17 June in Brussels.
As the EU prepares to implement the new Medical Devices Regulation in May 2020, the workshop will aim to explore what role clinical registries may play in informing regulators’ market surveillance activities, and to identify a possible “common framework” for EU registries responding to the needs of regulators, patients, physicians and industry alike.
The event will bring together key experts in data collection, review and management, including European Commission officials, healthcare professionals, regulators and industry representatives.
For more information, please find the programme here.
Spring meeting approaches
- Details
The BioMed Alliance organises its annual Spring Meeting on 14 May bringing together a diverse group of representatives from member societies. Delegates will meet in Brussels to discuss the European Elections, Plan S and Open Access Publishing and internal BioMed Alliance affairs.
During the morning session, high-level representatives from Wellcome trust and the European Commission will engage in a discussion on Plan S with publication experts from our member organisations. This is a topic of great interest as it potentially changes the publication landscape and has significant consequences for both researchers and academic societies.
The speaker list includes:
Keynote speaker: Robert Kiley, Head of Open Science at Wellcome Trust
- Panellists:
- Jean-Claude Burgelman, Head of Unit Open data Policies and Science Cloud, European Commission
- Prof. Laszlo Fesus, Chair of the FEBS Publications Committee
- Jan Cools, editor-in-chief of the HemaSphere journal, EHA
- Thomas F. Lüscher, editor in Chief of the European Heart Journal / Valentina Tursini, Scientific Publications Director, ESC
We look forward to fruitful discussions. The full programme and more information can be found here.
Medical societies unite for high quality CME
- Details
Medical societies from different disciplines cooperate within the Biomedical Alliance in Europe (BioMed Alliance) to work towards becoming a strong common voice for high-quality Continuing Medical Education (CME) in Europe. Medical societies play a key role in the provision of high-quality education to medical professionals e.g. in the form of congresses, e-learning modules, guidelines, journals and other scientific publications.
The BioMed Alliance taskforce on the future of CME has produced an article raising awareness on the importance of unbiased and qualitative medical education. The article was written by a number of leading academics and is published ahead of print by the American Journal of Medicine on PubMed. The aim of the article is to reflect on the role of industry in CME Provision and to identify the balance that is ultimately right for patients.
A CME Experts Standing Committee was also recently established to allow for continued discussions and cooperation on medical education. The Committee held its first formal meeting on 17 April and consists of experts in medical education from BioMed Alliance medical societies. The CME Experts Committee aims to foster cooperation between medical societies and explores potential actions to guarantee excellence of educational activities. It will work together with different stakeholders to set standards on how scientific societies plan and deliver educational programmes to achieve high quality medical education for the benefit of its members with an ultimate focus on better patient care.
BioMed Alliance expresses concerns on GDPR implementation in new statement
- Details
The Biomedical Alliance in Europe produced a statement outlining the practical consequences of the General Data Protection Regulation (GDPR) on health research. While the overarching purpose of the regulation is commendable, in practice researchers experience that its implementation hinders health research.
Bold vision needed to translate basic health research in to new ways of delivering healthcare and new treatments for patients
- Details
Scientific communities from industry and academia through the Biomedical Alliance in Europe (BioMed Alliance) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have teamed up to address the gaps within the translational research ecosystem and call for more focus and funding for translational research and pan European mechanisms for coordination and implementation.